Product image of Hypnomidate (Etomidate) supplied by GNH India

Hypnomidate

Active Ingredient:
Etomidate
Origin:
EU

Hypnomidate (Etomidate)

Etomidate, the active ingredient in Hypnomidate, is a sedative‑hypnotic (imidazoles) presented as an injectable solution for intravenous use. It is employed for the induction of general anesthesia and for sedation during endotracheal intubation in adult patients.

GNH India supplies Hypnomidate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Piramal Critical Care Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Etomidate is a rapid‑acting intravenous anesthetic used in the peri‑operative setting.

  • Induction of general anesthesia: provides swift unconsciousness for surgical procedures.
  • Sedation for endotracheal intubation: facilitates safe airway management by producing rapid hypnosis and muscle relaxation.

How It Works

  • Etomidate acts as a positive modulator of the GABA‑A receptor complex, enhancing the inhibitory chloride current. This potentiation increases neuronal membrane hyperpolarization, leading to rapid onset of sedation, hypnosis, and loss of consciousness without significant analgesic activity.

Side Effects

Etomidate may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Pain on injection: discomfort at the intravenous site.
  • Myoclonus: brief, involuntary muscle jerks.
  • Hypotension: transient drop in blood pressure.
  • Nausea and vomiting: gastrointestinal upset.
  • Respiratory depression: reduced breathing effort.
  • Dizziness: sensation of lightheadedness.

Serious or Rare Side Effects

  • Adrenal suppression: decreased cortisol synthesis.
  • Severe hypotension: profound circulatory collapse.
  • Cardiac arrhythmias: abnormal heart rhythms.
  • Anaphylaxis: life‑threatening allergic reaction.
  • Seizures: rare convulsive episodes.
  • Persistent apnea: prolonged cessation of breathing.

Precautions & Warnings

Etomidate requires careful monitoring and specific safety measures before and during administration.

  • Cardiovascular status: monitor blood pressure and heart rate continuously.
  • Respiratory function: ensure airway patency and adequate ventilation.
  • Adrenal function: avoid prolonged infusions in patients at risk of adrenal insufficiency.
  • Sepsis or infection: use with caution due to potential hemodynamic instability.
  • Concomitant CNS depressants: assess for additive sedation effects.
  • Store at ambient temperature: keep in original packaging, protect from light and moisture.

Avoid Interactions

Etomidate can interact with other medications, influencing its safety profile.

Major Interactions (Avoid)

  • Propofol: additive cardiovascular depression.
  • Opioids: enhanced respiratory depression.
  • Benzodiazepines: increased depth of sedation.

Moderate Interactions (Monitor Closely)

  • Inhalational anesthetics: cumulative depressant effect on the central nervous system.
  • Vasopressors: may require dose adjustments to maintain hemodynamic stability.
  • Anticonvulsants: potential alteration of seizure threshold.

Frequently Asked Questions

Hypnomidate contains etomidate, which is used primarily to induce rapid unconsciousness for general anesthesia and to provide sedation during endotracheal intubation. It is administered intravenously in controlled clinical settings such as operating rooms and emergency departments.

Etomidate enhances the activity of the GABA‑A receptor, the main inhibitory neurotransmitter system in the brain. By increasing chloride ion flow into neurons, it hyperpolarizes the cell membrane, leading to decreased neuronal firing and producing swift sedation and hypnosis.

The dosage of Hypnomidate is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and procedural requirements. Healthcare professionals calculate the appropriate intravenous dose and administer it under continuous monitoring.

The safety of etomidate in pregnancy and lactation has not been fully established. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To request Hypnomidate, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with agents such as propofol or thiopental, etomidate (Hypnomidate) offers hemodynamic stability with less impact on blood pressure, making it useful in patients with cardiovascular compromise. However, it may cause adrenal suppression and myoclonus, which are less common with alternative agents.

Hypnomidate should be stored at ambient temperature, protected from light and moisture, and kept in its original container. Do not freeze the product, and ensure that the vial or ampoule is inspected for any particulate matter before use.

Hypnomidate is given as an intravenous injection. The drug is typically administered as a rapid bolus over 30–60 seconds, followed by continuous monitoring of vital signs. In some cases, a maintenance infusion may be used under strict clinical supervision.

The most serious risks include severe hypotension, adrenal suppression leading to decreased cortisol production, respiratory depression, and rare but life‑threatening anaphylactic reactions. Prompt recognition and supportive measures are essential to manage these events.

Hypnomidate is contraindicated in patients with known hypersensitivity to etomidate or any component of the formulation. Caution is advised in individuals with severe adrenal insufficiency, uncontrolled sepsis, or those receiving other potent central nervous system depressants.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Etomidate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT